Endocrine Abstracts

Background: The presence of the metabolic syndrome (MS) increases cardiovascular morbidity and mortality but few data is available on the outcome in subjects with the MS and subclinical atherosclerosis.Aim: We aimed to assess cardio- and cerebro-vascular events in subjects with MS and subclinical atherosclerosis.Methods: We followed-up for 5 years 339 subjects with asymptomatic carotid intima-media thickness >0.9 mm, of whom 13...

Introduction: There is currently high interest in the non-glycemic effects of incretin-based therapies, specifically glucagon-like peptide 1 (GLP-1) analogues, such as those on cardiovascular system. Liraglutide has been approved in Italy since one year to be prescribed in combination with oral hypoglycemic agents; it has several non-glycemic properties, but its effect on carotid intima-media thickness (IMT), a recognized marker of subclinical atherosclerosis, is still unknown...

Background: Hashimoto’s thyroiditis (HT) is considered the most common autoimmune disease and the predominant cause of hypothyroidism in iodine sufficient countries. HT may appear clinically in approximately 0.1–2% of the population.Aim: The study in hand aimed at assessing the role of thyroid ultrasonography in the diagnosis of HT patients discriminating them from other causes of hypothyroidism. A scoring system of sonographic findings was a...